These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 203845)

  • 1. Pharmacological properties of (3H) dihydroergokryptine binding sites associated with alpha noradrenergic receptors in rat brain membranes.
    Greenberg DA; Snyder SH
    Mol Pharmacol; 1978 Jan; 14(1):38-49. PubMed ID: 203845
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional variations in alpha adrenergic receptor interactions of [3H]-dihydroergokryptine in calf brain: implications for a two-site model of alpha receptor function.
    Peroutka SJ; Greenberg DA; U'Prichard DC; Snyder SH
    Mol Pharmacol; 1978 May; 14(3):403-12. PubMed ID: 26861
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.
    Greenberg DA; Snyder SH
    Life Sci; 1977 Mar; 20(6):927-31. PubMed ID: 191710
    [No Abstract]   [Full Text] [Related]  

  • 4. [3H]Dihydroergocryptine binding to alpha adrenergic receptors in canine aortic membranes.
    Tsai BS; Lefkowitz RJ
    J Pharmacol Exp Ther; 1978 Mar; 204(3):606-14. PubMed ID: 24730
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.
    U'Prichard DC; Greenberg DA; Snyder SH
    Mol Pharmacol; 1977 May; 13(3):454-73. PubMed ID: 17827
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine.
    U'Prichard DC; Bechtel WD; Rouot BM; Snyder SH
    Mol Pharmacol; 1979 Jul; 16(1):47-60. PubMed ID: 39248
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of alpha-adrenergic receptors in guinea-pig vas deferens by [3H]dihydroergocryptine binding.
    Holck MI; Marks BH; Wilberding CA
    Mol Pharmacol; 1979 Jul; 16(1):77-90. PubMed ID: 225655
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for two alpha-adrenergic binding sites in liver plasma membranes. Studies with [3H]epinephrine and [3H]dihydroergocryptine.
    El-Refai MF; Blackmore PF; Exton JH
    J Biol Chem; 1979 Jun; 254(11):4375-86. PubMed ID: 35537
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
    Williams LT; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):304-13. PubMed ID: 192992
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL; Leslie FM
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denervation-induced changes in alpha and beta adrenergic receptors of the rat submandibular gland.
    Arnett CD; Davis JN
    J Pharmacol Exp Ther; 1979 Nov; 211(2):394-400. PubMed ID: 228025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph nodes--a possible site for sympathetic neuronal regulation of immune responses.
    Giron LT; Crutcher KA; Davis JN
    Ann Neurol; 1980 Nov; 8(5):520-5. PubMed ID: 6254440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific binding of 3H-guanfacine to alpha 2-adrenoceptors in rat brain. Comparison with 3H-clonidine.
    Dausse JP; Cardot A; Meyer P
    J Pharmacol; 1983; 14(1):35-46. PubMed ID: 6300560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroergocryptine: a "pseudo-irreversible" alpha-adrenergic antagonist in the guinea pig vas deferens.
    Wilberding CA; Marks BH
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):387-401. PubMed ID: 6265988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacology of central noradrenergic receptors (author's transl)].
    Besson MJ; Reisine TD
    Encephale; 1982; 8(2):177-92. PubMed ID: 6286276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-clonidine and 3H-p-aminoclonidine interactions in vitro with central and peripheral alpha 2-adrenergic receptors.
    U'Prichard DC
    Prog Clin Biol Res; 1981; 71():53-74. PubMed ID: 6276902
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct binding studies do not support the existence of true alpha-adreno-receptors in rat white fat cells.
    Giudicelli Y; Thotakura NR; Lacasa D; Pecquery R; Agli B
    Biochem Biophys Res Commun; 1981 May; 100(2):621-8. PubMed ID: 6268067
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
    Haga T; Haga K
    J Neurochem; 1981 Mar; 36(3):1152-9. PubMed ID: 6110704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct alpha1-adrenergic receptor sites in rat liver: differential binding of (--)-[3H]dihydroergocryptine. Effects of guanine nucleotides and proteolysis; implications for a two-site model of alpha-receptor regulation.
    Geynet P; Ferry N; Borsodi A; Hanoune J
    Biochem Pharmacol; 1981 Jun; 30(12):1665-75. PubMed ID: 6268106
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of ectopic alpha-adrenergic binding receptors of adrenocortical carcinoma cells.
    Shanker G; Sharma RK
    Endocrinology; 1980 May; 106(5):1594-8. PubMed ID: 6244938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.